BHIA
VRTX icon

Birch Hill Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Birch Hill Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.4M Sell
147,702
-3,093
-2% -$1.37M 2.97% 13
2026
Q1 		$67.3M Sell
150,795
-1,690
-1% -$788K 3.02% 12
2025
Q4 		$69.1M Sell
152,485
-1,117
-0.7% -$481K 2.89% 12
2025
Q3 		$60.2M Buy
153,602
+5,288
+4% +$2.21M 2.54% 13
2025
Q2 		$66M Buy
148,314
+10
+0% +$4.61K 2.93% 12
2025
Q1 		$71.9M Sell
148,304
-24,517
-14% -$11.4M 3.41% 9
2024
Q4 		$69.6M Buy
172,821
+4,664
+3% +$2.16M 3.24% 10
2024
Q3 		$78.2M Sell
168,157
-3,342
-2% -$1.61M 3.67% 8
2024
Q2 		$80.4M Sell
171,499
-231
-0.1% -$100K 3.89% 7
2024
Q1 		$71.8M Sell
171,730
-15,604
-8% -$6.6M 3.49% 7
2023
Q4 		$76.2M Buy
187,334
+1,654
+0.9% +$611K 4.06% 6
2023
Q3 		$64.6M Sell
185,680
-915
-0.5% -$320K 3.85% 8
2023
Q2 		$65.7M Sell
186,595
-4,835
-3% -$1.63M 3.77% 7
2023
Q1 		$60.3M Sell
191,430
-12,893
-6% -$3.87M 3.75% 5
2022
Q4 		$59M Sell
204,323
-6,173
-3% -$1.88M 3.76% 7
2022
Q3 		$60.9M Sell
210,496
-6,750
-3% -$1.94M 4.12% 5
2022
Q2 		$61.2M Sell
217,246
-16,856
-7% -$4.51M 3.82% 5
2022
Q1 		$61.1M Sell
234,102
-13,137
-5% -$3.12M 3.26% 9
2021
Q4 		$54.3M Buy
247,239
+50,095
+25% +$9.74M 2.69% 14
2021
Q3 		$35.8M Buy
197,144
+1,570
+0.8% +$307K 1.92% 23
2021
Q2 		$39.4M Buy
195,574
+39,389
+25% +$8.24M 2.12% 20
2021
Q1 		$33.6M Buy
+156,185
New +$34.3M 1.91% 24

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Birch Hill Investment Advisors's VRTX Position: Q2 2026 in Review

Birch Hill Investment Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 2.1% in Q2 2026, selling an estimated $1.37M and leaving 147,702 shares worth $73.4M. The position accounts for 2.97% of the portfolio, ranked #13.

Birch Hill Investment Advisors first reported a position in VRTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $80.4M in Q2 2024. 734 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Birch Hill Investment Advisors held 147,702 shares of Vertex Pharmaceuticals worth $73.4M as of Q2 2026.
  • Birch Hill Investment Advisors sold 3,093 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.37M.
  • Vertex Pharmaceuticals made up 2.97% of Birch Hill Investment Advisors's portfolio in Q2 2026, its #13 holding.
  • Birch Hill Investment Advisors first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Birch Hill Investment Advisors's Vertex Pharmaceuticals position peaked at $80.4M in Q2 2024.
  • 734 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Birch Hill Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.